Permissive Weight Bearing in Displaced Intra-articular Calcaneal Fractures (PIONEER)

October 15, 2024 updated by: Maastricht University Medical Center

(Cost-)effectiveness of Permissive Weight Bearing in Surgically Treated Trauma Patients with Displaced Intra-Articular Calcaneal Fractures: a Multicenter, Randomized Controlled Trial

The goal of the proposed study is to define the optimal rehabilitation for trauma patients with Displaced Intra-articular Calcaneal Fractures, either Permissive Weight Bearing (PWB) or Restricted Weight Bearing (RWB) regarding functional outcomes, health related quality of life, radiographical differences, cost-effectiveness and complications.

Study Overview

Detailed Description

Rationale: Of all fractures, 1-2% involve the calcaneus. Often surgical treatment is needed. Even after successful treatment it requires long rehabilitation with major impact on daily life and socio-economic aspects. Anatomic surgical restoration does not prevent gait disturbances or persistent foot pain. An adequate rehabilitation program is mandatory to maximize foot stability.

Objective: Evidence showing which rehabilitation protocol is best for both fracture healing and quality of life for patients with Displaced Intra-Articular Calcaneal Fractures (DIACFs) is mostly lacking. This study has the aim to answer the question whether surgically treated patients with DIACFs following the Permissive Weight Bearing protocol (PWB) have better functional outcomes compared to patients with Restricted Weight Bearing protocol after 12 weeks (RWB) measured with the American Orthopaedic Foot & Ankle Society (AOFAS) Score. The study hypothesizes that patients with DIACFs following the PWB protocol will have a better quality of life (HR-QOL) compared to patients who followed the RWB protocol.

The hypothesis is that there will be lower costs without any radiographic differences for surgically treated (irrespective of technique used) patients with DIACFs following a PWB protocol comparing to the current AO (Arbeitsgemeinschaft für Osteosynthesefragen) standard care: the RWB protocol.

Study design: Multi-center randomized controlled trial

Study population: Presence of surgically (extended lateral, sinus tarsi or percutaneous approach) fixed DIACFs classified as Sanders type II to IV, age 18-67 years (labor force). Patients must be able to understand and follow weight bearing instructions. Patients will only be included after written informed consent is obtained.

Groups (intervention and control): Patients with DIACFs will be randomly allocated to one of the rehabilitation protocols, either PWB or RWB.

Main study parameters/endpoints: Primary objective: functional outcome. Secondary outcomes: quality of life, differences in radiographic parameters, complications, cost effectiveness and differences in surgical techniques.

Nature and extent of the burden: The PWB protocol aims to restore weight bearing faster than RWB protocol in DIACFs. Early postoperative weight bearing poses the risk of increased complications, such as secondary displacement of the fracture or failure of fracture fixation. Previous analysis of this protocol in other lower extremity fractures has shown a safe complication rate, although data from prospective randomized trials in calcaneus fractures are lacking. Follow-up is standardized according to current trauma guidelines, namely at time points 2, 6, 12 weeks and 6 months. The radiation exposure will not be different from standard of care. Therefore, the burden for participants is considered minimal, with no significant health risks.

Study Type

Interventional

Enrollment (Estimated)

115

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Amsterdam, Netherlands
        • Not yet recruiting
        • Amsterdam University Medical Center
        • Contact:
          • Tim Schepers
          • Phone Number: MD
      • Arnhem, Netherlands
        • Not yet recruiting
        • Rijnstate Hospital
        • Contact:
          • Albert Pull ter Gunne, MD
      • Breda, Netherlands
        • Not yet recruiting
        • Amphia Hospital
        • Contact:
          • Niels Berende, MD
      • Den Haag, Netherlands
        • Not yet recruiting
        • Haaglanden Medical Center
        • Contact:
          • Jochem Hoogendoorn, MD
      • Eindhoven, Netherlands
        • Not yet recruiting
        • Catharina Hospital
        • Contact:
          • Alexander van der Veen, MD
      • Gouda, Netherlands
        • Not yet recruiting
        • Groene Hart Hospital
        • Contact:
          • Jan Siert Reinders, MD
      • Maastricht, Netherlands
        • Recruiting
        • Maastricht University Medical Center +
        • Contact:
          • Martijn Poeze, Prof.
      • Nijmegen, Netherlands
        • Recruiting
        • Radboud University Medical Center
        • Contact:
          • Erik Hermans, MD
      • Rotterdam, Netherlands
        • Not yet recruiting
        • Maasstad Hospital
        • Contact:
          • Kees van der Vlies, MD
      • Sittard, Netherlands
        • Not yet recruiting
        • Zuyderland Medical Center
        • Contact:
          • Raoul van Vugt, MD
      • Tilburg, Netherlands
        • Not yet recruiting
        • Elisabeth-Twee Steden Hospital
        • Contact:
          • Hilco Theeuwes, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 67 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Surgically treated trauma patients with isolated unilateral DIACFs, less than 6 weeks after trauma, Sanders type II-IV (14)
  • Age between 18 and 67 years old (labor force)
  • Being able to understand the questionnaires and measurement instructions
  • Indication for open/closed reduction and internal fixation
  • Written Informed Consent

Exclusion Criteria:

  • Acute or existing amputation (upper limb, lower limb, feet)
  • Open calcaneal fractures (excluding medial wound without compromising surgical approach)
  • Bilateral fractures of the lower extremities
  • Unable to comply to the PWB protocol due to pre-existing conditions of the arms and legs (e.g. unable to use crotches due to hemiparalysis)
  • Severe non-fracture related comorbidity of the lower extremity
  • Pre-existent immobility (loss of muscle function of one or both legs)
  • Dependent in activities of daily living (e.g. due to dementia, Alzheimer, New York Heart Association class IV angina, heart failure or oxygen-dependent chronic obstructive pulmonary disease)
  • Rheumatoid arthritis of the lower extremities
  • Severe psychiatric comorbidities that lead to inability to comply with the treatment protocol
  • Pathologic fractures (metastasis, secondary osteoporosis)
  • Peripheral neuropathy and/or diabetes
  • Alcohol- or drug abuse preventing adequate follow-up
  • Primary indication for arthrodesis subtalar joint
  • Two or more fractures of the upper and/or lower extremities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Permissive Weight Bearing group
Rehabilitation following the Permissive Weight Bearing (PWB) protocol
The Permissive Weight Bearing (PWB) protocol allows earlier post-operative permissive weight bearing, where progression of weight bearing is guided by the subjective experience (for example: pain, weight bearing tolerance) of the patient and the clinical expertise of the treating physician and therapist. Patients allocated to the PWB protocol start weight bearing after wound healing is achieved (approximately two weeks after the operation). Consequently, patients are stimulated to bear as much weight as tolerated by pain and comfort. Treatment will take place according to the PROMETHEUS protocol (treatment- and evaluation protocol). The protocol contains a number of weight bearing milestones (e.g. walking with two crutches, walking with two canes, walking with one cane and walking without any walking aids). The treating physiotherapist or physician records the dates that these milestones are reached in the study database.
Other Names:
  • Early Weight Bearing
Active Comparator: Restrictive Weight Bearing group
Rehabilitation following the Restrictive Weight Bearing (RWB) protocol
The Restrictive Weight Bearing (RWB) protocol consists of 8 to 12 weeks of postoperative restricted weight (0-10%) bearing, following the current AO Guidelines (7). After 8 weeks of restricted weight bearing, the weight bearing will be increased with 25% per week for 4 weeks. Every time the patient and the treating physical therapist or physician have contact, the weight bearing advice given to the patient at that point in time is recorded (unloaded; partial weight bearing + clarification; full weight bearing). Also, any additional advice given to the patient is recorded.
Other Names:
  • Non Weight Bearing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in functional outcome as defined by the AOFAS questionnaire
Time Frame: 0, 2, 6, 12 weeks and 6 months post-surgery.
The American Orthopaedic Foot & Ankle Society (AOFAS) score is a clinician-based score. It incorporates both subjective and objective information. Patients report their pain, and physicians assess alignment. It is designed for physicians to help standardize the assessment of patients and makes the results of this study comparable with previous data. Scores range from 0 to 100, with healthy foot and ankles receiving 100 points.
0, 2, 6, 12 weeks and 6 months post-surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported function with the Maryland Foot Score
Time Frame: 0, 2, 6, 12 weeks and 6 months post-surgery
The MFS is an assessment for foot disorders, mainly consisting of the following items: pain, gait, functional activities, and cosmesis. The scale scores have a minimum of 0 points and a maximum of 100 points. A total score of <50 is considered as poor, 50-74 as fair, 75-89 as good, and 90-100 as excellent.
0, 2, 6, 12 weeks and 6 months post-surgery
Activities of Daily Living (ADL) with LEFS
Time Frame: 0, 2, 6, 12 weeks and 6 months post-surgery
The lower extremity functional scale (LEFS) is a questionnaire containing 20 questions about a person's ability to perform everyday tasks. The LEFS can be used by clinicians as a measure of patients' initial function, ongoing progress, and outcome, as well as to set functional goals. The LEFS can be used to evaluate the functional impairment of a patient with a disorder of one or both lower extremities. It can be used to monitor the patient over time and to evaluate the effectiveness of an intervention. The questionnaire consists of 80 points. The lower the score the greater the disability.
0, 2, 6, 12 weeks and 6 months post-surgery
Health Related Quality of Life with EQ-5D-5L
Time Frame: 0, 2, 6, 12 weeks and 6 months post-surgery
The EuroQol 5-Dimension, 5-Level Health Scale (EQ-5D-5L) is a self-administered questionnaire, which will be completed at baseline together with the cost questionnaire at the same moments (0, 2, 6, 12 weeks and 6 months). Both generic quality of life, as well as utilities, will be derived by means of the EQ-5D-5L, which will be administered both by the patients. The Dutch version of the EQ-5D-5L is chosen because it is a widely used quality of life instrument (nationally and internationally) and it is recommended by the Dutch guidelines.The EQ-5D-5L contains 5 dimensions of health-related quality of life, namely mobility, self-care, daily activities, pain/discomfort and depression/anxiety. Each dimension can be rated at five levels: no problems to major problems. The 5 dimensions can be summed into a health state.
0, 2, 6, 12 weeks and 6 months post-surgery
Böhlers angle and posterior facet joint
Time Frame: Early postoperative (before first mobilization) and 6 months post-surgery

Radiographic evaluation by a radiologist blinded for treatment allocation will be done at the same time intervals as the scheduled visits to the physician.

To see if there is a difference in the alignment of Böhlers angle and posterior facet joint alignment (radiographically measured), a CT-scan will be performed early post-operatively (before first weight bearing) and after 6 months. Differences in the Böhlers angle and posterior joint alignment (Δ = CT6months - CTpost-op.) will be calculated. The normal degree for the Böhler angle varieties between 25° and 40°. An intra-articular step off or gap from less than 2mm of the posterior facet was considered as well-reduced.

Early postoperative (before first mobilization) and 6 months post-surgery
Medical consumption with iMCQ
Time Frame: 0 weeks and 6 months post-surgery
The iMTA Medical Consumption Questionnaire (iMCQ) measures health care utilization and is based on 29 questions. It is an instrument for measuring medical consumption and is related to frequently occurring contacts with health care providers. The iMCQ is a generic questionnaire. It is therefore not disease specific. The questions ask about health care related appointments patients had in the past period. In case the respondent had no appointments, the score '0' is noted.
0 weeks and 6 months post-surgery
Society costs with iPCQ
Time Frame: 0 weeks and 6 months post-surgery

The iMTA Productivity Cost Questionnaire (iPCQ) measures productivity losses. The questionnaire is based on 12 questions. Questions 1 to 3 give information about the amount of paid work (in hours) and the number of days per week on which the respondent works. The latter provides insight into the average number of hours of work per working day of the respondent. This information is needed to calculate productivity loss costs.

The questions about productivity losses form the following modules:

  • Absenteeism: absenteeism from paid work (questions 4 to 6)
  • Presenteeism: productivity losses during days worked (questions 7 to 9)
  • Productivity loss from unpaid work (questions 10 to 12). After completing the questionnaire the total amount of absenteeism can be calculated by multiplying the number of days absent and the number of hours per working day of the respondent.

To calculate the costs of productivity losses, volumes are multiplied by unit cost prices.

0 weeks and 6 months post-surgery
Occurrence of complications
Time Frame: 6 and 12 weeks and 6 months post-surgery
Most important complications, such as: wound infection, dislocation, non-union, - failure of osteosynthesis, postoperative arthritis
6 and 12 weeks and 6 months post-surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2024

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

January 1, 2026

Study Registration Dates

First Submitted

January 13, 2023

First Submitted That Met QC Criteria

February 7, 2023

First Posted (Actual)

February 10, 2023

Study Record Updates

Last Update Posted (Actual)

October 17, 2024

Last Update Submitted That Met QC Criteria

October 15, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • PIONEER

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma Injury

Clinical Trials on Permissive Weight Bearing group

Subscribe